Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA Hiring Initiative Aims To Get Scientific Staff More Involved In Recruitment

Executive Summary

Commissioner Gottlieb's pilot program also creates dedicated recruitment staff that will work to fill prescription drug user fee-related openings, streamline the hiring process and improve employee retention.

You may also be interested in...



US FDA's Hiring: First Phase Of Cures Implementation Will Focus On Senior Staff

Workforce report to Congress, mandated by 21st Century Cures Act, details FDA's plans for implementing its new authorities provided by the law. 

Gottlieb Highlights Drawback To Increasing FDA Salaries: Resource Disparity

FDA commissioner tells agency stakeholders that there could be intra-agency moves to centers and offices that can offer higher pay.

Gottlieb Highlights Drawback To Increasing US FDA Salaries: Resource Disparity

Commissioner tells agency stakeholders that there could be intra-agency moves to centers and offices that can offer higher pay.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS121123

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel